Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, immunology, neuroscience, ophthalmology, and infectious diseases and vaccines. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,300 people across 46 countries.
